These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22370987)

  • 21. Classification of lung cancer.
    Travis WD
    Semin Roentgenol; 2011 Jul; 46(3):178-86. PubMed ID: 21726702
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical impact of the use of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers.
    Lyons G; Quadrelli S; Jordan P; Colt H; Chimondeguy D
    Lung Cancer; 2011 Nov; 74(2):244-7. PubMed ID: 21411177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transbronchial biopsy of the lung in the diagnosis of peripheral cancer and diffuse-disseminated processes].
    Lebedev VA; Blinchevskiĭ ID
    Sov Med; 1990; (9):107-11. PubMed ID: 2176348
    [No Abstract]   [Full Text] [Related]  

  • 24. Subsolid pulmonary nodules: CT-pathologic correlation using the 2011 IASLC/ATS/ERS classification.
    Liao JH; Amin VB; Kadoch MA; Beasley MB; Jacobi AH
    Clin Imaging; 2015; 39(3):344-51. PubMed ID: 25709110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing a specific pathologic diagnosis of non-small-cell lung carcinoma.
    Sulpher JA; Owen SP; Hon H; Tobros K; Shepherd FA; Sabri E; Gomes M; Sekhon H; Liu G; Canil CM; Wheatley-Price P
    Clin Lung Cancer; 2013 May; 14(3):238-44. PubMed ID: 23291255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subtyping lung adenocarcinoma according to the novel 2011 IASLC/ATS/ERS classification: correlation with patient prognosis.
    Okada M
    Thorac Surg Clin; 2013 May; 23(2):179-86. PubMed ID: 23566969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practice guidelines for non-small cell lung cancer.
    Cameron R; Fringer J; Taylor C; Gilden CR; Figlin RA
    Cancer J Sci Am; 1996; 2(3A Suppl):S61-8. PubMed ID: 9166525
    [No Abstract]   [Full Text] [Related]  

  • 28. [Which initial evaluation for non-small-cell bronchial cancers?].
    Milleron B
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S120-1. PubMed ID: 10088279
    [No Abstract]   [Full Text] [Related]  

  • 29. [The need for new techniques in the diagnosis and staging of lung cancer].
    Fernández-Villar A; Leiro-Fernández V; Botana-Rial M
    Arch Bronconeumol; 2010 Jun; 46(6):336-8. PubMed ID: 20116917
    [No Abstract]   [Full Text] [Related]  

  • 30. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
    Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The nuclear morphometry by image analysis in the histopathologic diagnosis of lung cancer.
    Kavantzas N; Lazaris AC; Chatzigianni E; Davaris PS
    J Exp Clin Cancer Res; 2000 Jun; 19(2):201-6. PubMed ID: 10965819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung.
    Cagle PT; Sholl LM; Lindeman NI; Alsabeh R; Divaris DX; Foulis P; Lee G; Neal JW; Nowak JA; Yu PP;
    Arch Pathol Lab Med; 2014 Feb; 138(2):171-4. PubMed ID: 23808401
    [No Abstract]   [Full Text] [Related]  

  • 33. [Understanding and appraisal of the new TNM classification for esophageal cancer in the AJCC Cancer Staging Manual (7th edition)].
    Chen LQ
    Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):237-40. PubMed ID: 20450597
    [No Abstract]   [Full Text] [Related]  

  • 34. Histologic type definition in clinical trials on advanced non-small cell lung cancer.
    Rossi G; Cavazza A
    J Thorac Oncol; 2011 Feb; 6(2):405. PubMed ID: 21252724
    [No Abstract]   [Full Text] [Related]  

  • 35. Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review.
    Field RW; Smith BJ; Platz CE; Robinson RA; Neuberger JS; Brus CP; Lynch CF
    J Natl Cancer Inst; 2004 Jul; 96(14):1105-7. PubMed ID: 15265973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytological cell blocks: Predictors of squamous cell carcinoma and adenocarcinoma subtypes.
    Loukeris K; Vazquez MF; Sica G; Wagner P; Yankelevitz DF; Henschke CI; Cham MD; Saqi A
    Diagn Cytopathol; 2012 May; 40(5):380-7. PubMed ID: 22508674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM classification based on recommendations of the IASLC Staging Committee.
    Travis WD;
    Histopathology; 2009 Jan; 54(1):3-11. PubMed ID: 19187176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do we need a size-based subclassification for lung cancers larger than 3 cm?
    Pramesh CS; Mistry RC; Agarwal J
    Lung Cancer; 2005 Jul; 49(1):133-4; author reply 135. PubMed ID: 15949601
    [No Abstract]   [Full Text] [Related]  

  • 39. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-sized-based descriptors in staging of stage I non-small cell lung cancer.
    López-Encuentra A
    Chest; 2008 Sep; 134(3):673-674. PubMed ID: 18779213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.